Angiotensin II related to sodium exertion modulates left ventricular structure in human essential hypertension

Circulation

Volumn 94, Issue 6, 1996, Pages 1304-1309

  Schmieder, Roland E ^a   Langenfeld, Matthias R W ^a   Friedrich, Anja ^a   Schobel, Hans P ^a   Gatzka, Christoph D ^a   Weihprecht, Horst ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

angiotensin; hypertension; hypertrophy; sodium; ventricles

Indexed keywords

ANGIOTENSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT;

ADULT; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL FEATURE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM URINE LEVEL;

EID: 0029817978     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.6.1304     Document Type: Article

References (44)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990; 322:1561-1566.
2. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991; 114:345-352.
3. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men, Ann Intern Med. 1986;105:173-178.
4. Iso H, Kiyama M, Doi M, Nakanishi N, Kitamura A, Naito Y, Sato S, Iida M, Konishi M, Shimamoto T, Komachi Y. Left ventricular mass and subsequent blood pressure changes among middle-aged men in rural and urban Japanese populations. Circulation. 1994; 89:1717-1724.
5. De Simone G, Devereux RB, Roman MJ, Schlussel Y, Alderman MH, Laragh JH. Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension. Ann Intern Med. 1991; 114:202-209.
6. Post WS, Larson MG, Levy D. Impact of left ventricular structure on the incidence of hypertension. Circulation. 1994;90:179-185.
7. Liebson PR, Grandits G, Prineas R, Dianzumba S, Flack JM, Cutler JA, Grimm R, Stamler J. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation. 1993;87:476-486.
8. Messerli FH, Sundgaard-Riise K, Ventura HO, Dunn FG, Oigmann W, Frohlich ED. Clinical and hemodynamic determinants of left ventricular dimensions. Arch Intern Med. 1984;144:477-481.
9. Verdecchia P, Schillaci G, Boldrini F, Guerrieri M, Porcellati C. Sex, cardiac hypertrophy and diurnal blood pressure variations in essential hypertension. J Hypertens. 1992;10:683-692.
10. Marcus R, Krause L, Weder AB, Dominguez-Meija A, Schork NJ, Julius S. Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation. 1994;90:928-936.
11. Dunn FG, Oigman W, Sundgaard-Riise K, Messerli FH, Ventura H, Reisin E, Frohlich ED. Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes. J Am Coll Cardiol. 1983;1:1348-1351.
12. Harshfield GA, Koelsch DW, Pulliam DA, Alpert BS, Ritchey PA, Becker JA. Racial differences in the age-related increase in left ventricular mass in youths. Hypertension. 1994;24:747-751.
13. Hammond IW, Devereux RB, Alderman MH, Laragh JH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol. 1988;12:996-1004.
14. Schmieder RE, Messerli FH. Does obesity influence early target organ damage in hypertensive patients? Circulation. 1993;87:1482-1488.
15. Corea L, Bentivoglio M, Verdecchia P, Motolese M. Left ventricular wall thickness and plasma catecholamines in borderline and stable essential hypertension. Eur Heart J. 1982;3:164-170.
16. Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Dietary salt intake: a determinant of cardiac involvement in essential hypertension. Circulation. 1988;78:951-956.
17. Du Cailar G, Ribstein J, Daures JP, Mimran A. Sodium and left ventricular mass in untreated hypertensive and normotensive subjects. Am J Physiol. 1992;263:H177-H181.
18. Daniels SD, Meyer RA, Loggie JMH. Determinants of cardiac involvement in children and adolescents with essential hypertension. Circulation. 1990;82:1243-1248.
19. Kupari M, Koskinen P, Virolainen J. Correlates of left ventricular mass in a population sample aged 36 to 37 years. Circulation. 1994;89:1041-1050.
20. Geenen DL, Malhotra A, Scheuer J. Angiotensin II increases cardiac protein synthesis in adult rat heart. Am J Physiol. 1993;265:H238-H243.
21. Katoh Y, Komuro I, Shibasaki Y, Yamaguchi H, Yazaki Y. Angiotensin II induces hypertrophy and oncogene expression in cultured rat heart myocytes. Circulation. 1989;80(suppl II):II-450. Abstract.
22. Kent RL, Houber JK, Cooper G IV. Load responsiveness of protein synthesis in adult mammalian myocardium: role of cardiac deformation linked to sodium influx. Circ Res. 1989;64:74-85.
23. Nagano M, Higaki J, Mikami H, Nakamaru M, Higashimori K, Katahira K, Tabuchi Y, Moriguchi A, Nakamura F, Ogihara T. Converting enzyme inhibitors regressed cardiac hypertrophy and reduced tissue angiotensin II in spontaneously hypertensive rats. J Hypertens. 1991;9:595-599.
24. 1 expression. Hypertension. 1994;23:587-592.
25. Schmieder RE, Messerli FH, Garavaglia GE, Nunez B, MacPhee AA, Re RN. Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension? Am J Med. 1988;84(suppl 3A):136-139.
26. Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension: meta-analysis of studies with high scientific quality. J Am Coll Cardiol. 1995;25(suppl):300A. Abstract.
27. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens. 1992;5:95-110.
28. De Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH. Assessment of left ventricular function in the midwall fractional shortening/end systolic stress relation in human hypertension. J Am Coll Cardiol. 1994;23:1444-1451.
29. Sahn DF, de Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a sur vey of echoeardiographic measurements. Circulation. 1978;58: 1072-1080.
30. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;56:450-458.
31. Luft FC, Fineberg NS, Sloan RS. Estimating dietary sodium intake in individuals receiving a randomly fluctuating intake. Hypertension. 1982;4:805-808.
32. Siersbaek-Nielsen K, Molholm Hansen J, Kampmann J, Kristensen M. Rapid evaluation of creatinine clearance. Lancet. 1971;1:1133-1134.
33. Cockroft DW, Goult H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
34. Mann JFE, Johnson AK, Ganten D. Plasma angiotensin II: dipsogenetic level and the angiotensin generating capacity of renin. Am J Physiol. 1980;238:R372-R377.
35. Norusis MJ. SPSS. In: SPSS for Windows, Professional Statistics, Release 6.0. Chicago, 111: SPSS Inc: 1993.
36. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JH. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol. 1986;7:639-650.
37. Rizzoni D, Muiesan ML, Montani G, Zulli R, Calebich S, Agabiti-Rosei E. Relationship between initial cardiovascular structural changes and daytime and nighttime blood pressure monitoring. Am J Hypertens. 1992;5:180-186.
38. Prisant LM, Carr AA. Ambulatory blood pressure monitoring and echocardiographic left ventricular wall thickness and mass. Am J Hypertens. 1990;3:81-89.
39. Hollenberg NK, Moor TJ, Schoback TM, Redgrave J, Rabinova S, Williams GH. Abnormal renal sodium handling in essential hypertension: relation to failure of renal and adrenal modulation of responses to angiotensin II. Am J Med. 1986;81:412-418.
40. Brunner HR, Laragh JH, Baer L, Newton MA, Goodwin FT, Krakoff LR, Bard RH, Bühler FR. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med. 1972;286:441-449.
41. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 1991; 324:1098-1104.
42. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation. 1990;81:815-820.
43. Devereux RB, Savage DD, Drayer JIM, Laragh JH. Left ventricular hypertrophy and function in high, normal and low-renin forms of essential hypertension. Hypertension. 1982;4:524-531.
44. Vensel LA, Devereux RB, Pickering TG, Herrold EM, Borer JS, Laragh JH. Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis. Am J Cardiol. 1986;58:575-582.